{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:56:46Z","timestamp":1789408606142,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.biologicals.2009.01.001","type":"journal-article","created":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T09:20:13Z","timestamp":1233480013000},"page":"119-126","source":"Crossref","is-referenced-by-count":39,"title":["The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines"],"prefix":"10.1016","volume":"37","author":[{"given":"B.","family":"Kr\u00e4mer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Schildger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Behrensdorf-Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Hanschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Duchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2009.01.001_bib1","article-title":"WHO Expert Committee on rabies, 8th report","year":"1992"},{"key":"10.1016\/j.biologicals.2009.01.001_bib2","series-title":"Laboratory techniques in rabies","first-page":"279","article-title":"The NIH test for potency","author":"Seligman","year":"1973"},{"key":"10.1016\/j.biologicals.2009.01.001_bib3","series-title":"Rabies vaccine for human use prepared in cell cultures","year":"2008"},{"key":"10.1016\/j.biologicals.2009.01.001_bib4","series-title":"Rabies vaccine (inactivated) for veterinary use","year":"2008"},{"key":"10.1016\/j.biologicals.2009.01.001_bib5","first-page":"93","article-title":"Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model","volume":"64","author":"Bruckner","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2009.01.001_bib7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0264-410X(94)80049-6","article-title":"Immunogenicity of rabies vaccines used during an urban epizootic of rabies in Mexico","volume":"12","author":"Eng","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2009.01.001_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","article-title":"In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody","volume":"18","author":"Perrin","year":"1990","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.01.001_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1045-1056(05)80051-X","article-title":"Rabies vaccine standardization: international collaborative study for the characterization of the fifth International standard for rabies vaccine","volume":"20","author":"Lyng","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.01.001_bib10","series-title":"Animal welfare aspects in the quality control of immunobiologicals","author":"Wei\u00dfer","year":"1997"},{"key":"10.1016\/j.biologicals.2009.01.001_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0092-1157(84)80008-6","article-title":"A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein","volume":"12","author":"Ferguson","year":"1984","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib12","first-page":"57","article-title":"Collaborative study for the establishment of rabies vaccine (inactivated) for veterinary use","volume":"2","author":"Milne","year":"2000","journal-title":"Pharmeuropa Bio"},{"key":"10.1016\/j.biologicals.2009.01.001_bib13","first-page":"17","article-title":"Establishment of batch 4 of the biological reference preparation (BRP) for rabies vaccine (inactivated) for veterinary use","volume":"1","author":"Daas","year":"2004","journal-title":"Pharmeuropa Bio"},{"key":"10.1016\/j.biologicals.2009.01.001_bib14","series-title":"Report of the annual meeting 2007 of the CA\/OMCLs involved in the control of immunological veterinary medicinal products in Prague","author":"Milne","year":"2007"},{"key":"10.1016\/j.biologicals.2009.01.001_bib15","first-page":"137","article-title":"Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines","volume":"86","author":"Rooijakkers","year":"1996","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-0934(95)01999-5","article-title":"Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing","volume":"58","author":"Rooijakkers","year":"1996","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2009.01.001_bib17","article-title":"WHO Expert Committee on rabies, 7th report","year":"1984"},{"key":"10.1016\/j.biologicals.2009.01.001_bib18","first-page":"183","article-title":"Use of the antibody assay in immunized mice for the determination of rabies vaccine potency","volume":"40","author":"Fitzgerald","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0092-1157(79)80024-4","article-title":"A microtest for the quantitation of rabies virus neutralizing antibodies","volume":"7","author":"Zalan","year":"1979","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib20","series-title":"Human rabies immunoglobulin","year":"2008"},{"key":"10.1016\/j.biologicals.2009.01.001_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0264-410X(91)90188-C","article-title":"The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines","volume":"9","author":"Wunderli","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2009.01.001_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/1045-1056(90)90030-4","article-title":"Rabies reference vaccine for use as a regional standard for Latin America and the Caribbean countries","volume":"18","author":"Diaz","year":"1990","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.01.001_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0092-1157(89)90019-X","article-title":"Potency assay of antibodies against rabies. A report on a collaborative study","volume":"17","author":"Lyng","year":"1989","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.biologicals.2009.01.001_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2460\/ajvr.2003.64.491","article-title":"Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice","volume":"64","author":"Wunderli","year":"2003","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.biologicals.2009.01.001_bib26","series-title":"Grundlagen der Versuchstierkunde","first-page":"269","article-title":"Versuchsmethoden","author":"Baumans","year":"1995"},{"key":"10.1016\/j.biologicals.2009.01.001_bib27","series-title":"Tierschutzaspekte bei der Immunisierung von Versuchstieren","author":"Nicklas","year":"1997"},{"key":"10.1016\/j.biologicals.2009.01.001_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0092-1157(85)80017-2","article-title":"The mouse neutralization test in comparison with the rapid fluorescent focus inhibition test: differences in the results in rabies antibody determinations","volume":"13","author":"Haase","year":"1985","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib29","first-page":"99","article-title":"Comparative studies of two potency tests for antirabies serum: neutralization test in mice (MNT) and rapid fluorescent focus inhibition test (RFFIT)","volume":"64","author":"Kurz","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib30","series-title":"Laboratory techniques in rabies","first-page":"354","article-title":"A rapid tissue culture test for determining rabies neutralizing antibody","author":"Smith","year":"1973"},{"key":"10.1016\/j.biologicals.2009.01.001_bib31","series-title":"The principles of humane experimental technique","author":"Russel","year":"1959"},{"key":"10.1016\/j.biologicals.2009.01.001_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2460\/ajvr.2003.64.499","article-title":"Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice","volume":"64","author":"Wunderli","year":"2003","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.biologicals.2009.01.001_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2460\/ajvr.1997.58.08.837","article-title":"Evaluation of an animal rabies vaccine by use of two types of potency tests","volume":"58","author":"Baer","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.biologicals.2009.01.001_bib34","series-title":"Laboratory animals in vaccine production and control","first-page":"125","article-title":"Opportunities for replacement, reduction or refinement: veterinary vaccines for mammals","author":"Hendriksen","year":"1988"},{"key":"10.1016\/j.biologicals.2009.01.001_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.01.001_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.01.001_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1045-1056(05)80062-4","article-title":"Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use","volume":"20","author":"Ferguson","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2009.01.001_bib38","series-title":"Progress in rabies control","first-page":"311","article-title":"Is the NIH mouse potency test replaceable by the single radial immunodiffusion test","author":"Gerstl","year":"1988"},{"key":"10.1016\/j.biologicals.2009.01.001_bib39","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1016\/j.vaccine.2006.06.078","article-title":"The rabies peripheral challenge test: more accurate determination of vaccine potency","volume":"24","author":"Wunderli","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2009.01.001_bib40","first-page":"87","article-title":"Validation of an in vitro assay for the determination of rabies antigen","volume":"64","author":"Barth","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2009.01.001_bib41","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105609000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105609000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T21:57:47Z","timestamp":1710021467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105609000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1045105609000025"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2009.01.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}